December 16, 2022
December 16, 2022 - AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved Vraylar ® (cariprazine) as an adjunctive
- Have any questions?
- +1-888-INTL-SOS
- support@globalreachhealth.com
News
December 16, 2022
December 16, 2022 – Ferring Pharmaceuticals today announced the U.S. Food and Drug Administration (FDA) approved Adstiladrin ® (nadofaragene firadenovec-vncg)
December 14, 2022
December 14, 2022 – Thea Pharma, Inc. ("Thea"), the U.S. subsidiary of Europe’s leading independent pharmaceutical company, Laboratoires Thea
December 13, 2022
December 13, 2022 - ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company
dedicated to manufacturing, marketing and developing
December 13, 2022
December 13, 2022 – Idacio (adalimumab-aacf), a tumor necrosis factor (TNF) blocker biosimilar to Humira, has been approved by the FDA for the treatment of rheumatoid arthritis
December 12, 2022
December 12, 2022 – The FDA has granted accelerated approval to Mirati Therapeutics’ Krazati
(adagrasib)
November 18, 2022
November 18, 2022 - Jazz Pharmaceuticals plc announced the FDA approval of a supplemental Biologics
License Application
July 19, 2022
July 19, 2022 – Incyte's OpzeluraTM (ruxolitinib) cream has been approved for the topical treatment of nonsegmental vitiligo in patients who are at least 12 years old.